Dr Reddy's Laboratories Ltd. (DRREDDY)

Trade DRREDDY now with
5/20/2020 6:50:00 AM Dr. Reddy's Q4 Revenue Rs. 4,432 Cr, Up 10% From Last Year
5/6/2020 3:41:02 AM Dr. Reddy's Laboratories Unveils Desmopressin Acetate Injection USP, 4 Mcg/mL In The U.S. Market
4/27/2020 3:26:31 AM Dr. Reddy's Laboratories Unveils Fenofibrate Tablets USP, In The U.S. Market
4/14/2020 5:23:41 AM Dr. Reddy's Announces Launch Of Authorized Generic Version Of NitroDur Transdermal Infusion System
4/14/2020 5:20:44 AM Dr. Reddy's Labs Says Launches Amphetamine Sulfate Tablets USP In The U.S.
3/20/2020 1:41:36 AM Dr. Reddy's Launches Pyrimethamine Tablets USP, 25 Mg, Generic Version Of Daraprim(r) In U.S. Market
3/19/2020 2:55:03 AM Dr. Reddy's Unveils Naloxone Hydrochloride Injection USP, 2 Mg/2 ML (1 Mg/mL) Single-dose Prefilled Syringe In U.S.
3/17/2020 5:56:39 AM Dr. Reddy's Laboratories Unveils Ziprasidone Mesylate For Injection In The U.S. Market
2/27/2020 4:05:59 AM Dr. Reddy's Announces First Generic Launch Of Naproxen And Esomeprazole Magnesium Delayed-Release Tablets In U.S. Market